Serine Peptidase Inhibitor, Kazal Type 7 (Putative) Proteine (SPINK7)

Probable serine protease inhibitor.. Zusätzlich bieten wir Ihnen Serine Peptidase Inhibitor, Kazal Type 7 (Putative) Antikörper (44) und Serine Peptidase Inhibitor, Kazal Type 7 (Putative) Kits (12) und viele weitere Produktgruppen zu diesem Protein an.

alle Proteine anzeigen Gen GeneID UniProt
Ratte SPINK7 SPINK7 408237  
SPINK7 84651 P58062
SPINK7 408198  
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top Serine Peptidase Inhibitor, Kazal Type 7 (Putative) Proteine auf antikoerper-online.de

Showing 7 out of 8 products:

Katalog Nr. Origin Quelle Konjugat Bilder Menge Anbieter Lieferzeit Preis Details
Insektenzellen Human His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg Anmelden zum Anzeigen 50 Days
$6,749.58
Details
Insektenzellen Maus His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg Anmelden zum Anzeigen 50 Days
$6,749.58
Details
Escherichia coli (E. coli) Human His tag 50 μg Anmelden zum Anzeigen 13 bis 16 Tage
$400.00
Details
Wheat germ Human GST tag 10 μg Anmelden zum Anzeigen 11 bis 12 Tage
$414.29
Details
HEK-293 Cells Human Myc-DYKDDDDK Tag Validation with Western Blot 20 μg Anmelden zum Anzeigen 11 Days
$888.80
Details
Human Cells Human His tag   10 μg Anmelden zum Anzeigen 15 bis 16 Tage
$300.00
Details
Huhn Huhn Unkonjugiert   10 mg Anmelden zum Anzeigen 9 bis 11 Tage
$413.21
Details

SPINK7 Proteine nach Spezies und Herkunft

Origin Exprimiert in Konjugat
Human , , , ,
, ,
Mouse (Murine)

Weitere Proteine zu Serine Peptidase Inhibitor, Kazal Type 7 (Putative) (SPINK7) Interaktionspartnern

Human Serine Peptidase Inhibitor, Kazal Type 7 (Putative) (SPINK7) Interaktionspartner

  1. n cultured keratinocytes, SPINK7 mRNA expression was up-regulated by IL-17A together with IFNgamma

  2. Negative regulation of RNA-binding protein HuR by tumor-suppressor ECRG2

  3. ECRG2 in combination with cisplatin (DDP) can inhibit viability and induce apoptosis in esophageal cancer DDP-resistant cells, possibly via upregulation of p53 expression and downregulation of PCNA expression.

  4. miR-1322 can regulate ECRG2 in an allele-specific manner and that serum levels of miR-1322 can serve as a potential diagnostic biomarker for patients with ESCC.

  5. Conformational study of ECRG2 using NMR.

  6. ECRG2 is a novel member of the Kazal-type serine protease inhibitor family and may function as a tumor suppressor gene regulating the protease cascades during carcinogenesis and invasion of esophageal cancer.

  7. ECRG2 regulates invasion/migration partly through ECM degradation and uPA/uPAR/FPRL1 pathway

  8. Data suggest that the physical interaction of esophageal cancer related gene 2 (ECRG2) and metallothionein 2A (MT2A) may play an important role in the carcinogenesis of esophageal cancer.

  9. Potential interaction partner for ECRG2 might be involved in regulation of cell proliferation and apoptosis and in various physiological processes.

  10. Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer

  11. Short tandem repeat polymorphism TCA3/TCA3 in exon 4 of ECRG2 is associated with poor relapse-free survival in surgically completely resected oral squamous cell carcinoma patients and might be a potential prognostic marker

  12. results suggest that ECRG2 inhibits aggressiveness of cancer cell, possibly through the down-regulation of uPA/plasmin activity

  13. genetically fixed short tandem repeat polymorphism TCA3/TCA3 in exon 4 of ECRG2 is associated with poor clinical outcome in surgically treated esophageal cancer patients and might be a potential prognostic marker

  14. ECRG2 is important for ensuring centrosome duplication, spindle assembly checkpoint, and accurate chromosome segregation, and its depletion may contribute to chromosome instability and aneuploidy in human cancers.

  15. the ECRG2 TCA (3)/TCA (4) genotype is associated with the risk of oesophageal carcinoma in a North Indian population.

  16. uPA-binding loops of ECRG2 are in correspondence with the reactive site loops for binding of serine proteinase in turkey ovomucoid third domain (OMTKY3).

  17. ECRG2 is involved in the regulation of cell migration/invasion through uPA/uPAR/beta1 integrin pathway.

Serine Peptidase Inhibitor, Kazal Type 7 (Putative) (SPINK7) Protein Überblick

Protein Überblick

Probable serine protease inhibitor.

Genbezeichner und Symbole assoziert mit SPINK7

  • serine peptidase inhibitor, Kazal type 7 (Spink7)
  • serine peptidase inhibitor, Kazal type 7 (putative) (SPIK7)
  • serine peptidase inhibitor, Kazal type 7 (putative) (SPINK7)
  • serine peptidase inhibitor, Kazal type 7 (putative) (Spink7)
  • ECG2 Protein
  • ECRG2 Protein
  • EG408198 Protein
  • OM Protein

Bezeichner auf Proteinebene für SPINK7

ECRG-2 , esophagus cancer-related gene 2 protein , esophagus cancer-related protein 2 , serine peptidase inhibitor, Kazal type 7 (putative) , serine protease inhibitor Kazal-type 7 , allergen Gal d 1 , allergen Gal d I , ovomucoid , esophagus cancer related gene 2 , esophagus cancer-related gene-2

GENE ID SPEZIES
408237 Rattus norvegicus
416236 Gallus gallus
84651 Homo sapiens
408198 Mus musculus
Ausgewählte Anbieter für Serine Peptidase Inhibitor, Kazal Type 7 (Putative) Proteine (SPINK7)
Haben Sie etwas anderes gesucht?